How much funding has CHOSEN DIAGNOSTICS INC raised?

CHOSEN DIAGNOSTICS INC has raised $2.1M in total funding, most recently a Grant round.

Who are CHOSEN DIAGNOSTICS INC's investors?

CHOSEN DIAGNOSTICS INC's investors include National Institutes of Health.

When was CHOSEN DIAGNOSTICS INC founded?

CHOSEN DIAGNOSTICS INC was founded in 2019.

Where is CHOSEN DIAGNOSTICS INC headquartered?

CHOSEN DIAGNOSTICS INC is headquartered in NEW ORLEANS, Louisiana, United States.

What industry is CHOSEN DIAGNOSTICS INC in?

CHOSEN DIAGNOSTICS INC operates in Biotech, Healthcare.

How many employees does CHOSEN DIAGNOSTICS INC have?

CHOSEN DIAGNOSTICS INC has 1-10 employees.

CHOSEN DIAGNOSTICS INC

HOME | CHOSEN DIAGNOSTICS

NEW ORLEANS, United States · Founded 2019 · $2.1M raised

Biotech

Healthcare

Headquarters: NEW ORLEANS, Louisiana
Employees: 1–10
Founded: 2019
Business Model: B2B

Website: chosendiagnostics.com
Total Funding: $2.1M
Last Round: $2.1M GrantJan 2021
Rounds: 2

About

Chosen Diagnostics is an award-winning, female-owned small business developing noninvasive diagnostic biomarker tests for life-threatening neonatal diseases. Its lead product, NECDetect, uses a stool-based biomarker panel to diagnose necrotizing enterocolitis in preterm infants with 93% sensitivity. The company holds FDA Breakthrough Device designation and has received over $4M in NIH and NSF SBIR grants.

Summary

CHOSEN DIAGNOSTICS INC is a Biotech company based in NEW ORLEANS, United States, founded in 2019. It has raised $2.1M in total across 2 rounds, most recently a $2.1M Grant round in Jan 2021. Investors include National Institutes of Health.